|Composition||ENZULUTAMIDE 40 MG|
|Prescription/Non prescription||Non prescription|
|Therapeutic Uses||Enzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and|
|Treatment||Enzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and|
Obnyx is an androgen receptor inhibitor used to treat castration-resistant prostate cancer.
Obnyx is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
Obnyx is also used to associated treatment for these conditions: Metastatic Castration Resistant Prostate Cancer
- Delivery Time: 10 TO 12 DAYS